A study led by scientists at University of St Andrews has found that antibiotics used to treat tuberculosis kill other potentially useful bacteria.

A UK-wide research team, led by the Schools of Physics and Astronomy and Medicine at the University of St Andrews, has developed an innovative way to monitor the reaction of living bacteria to antibiotics using lasers and sound.

New medical advances could revolutionise the ability to treat undetected tuberculosis (TB) thanks to an international team of scientists led by the University of St Andrews

LifeArc, the medical research charity, and the University of St Andrews Infection Group today (August 7) announced a partnership to develop a molecular diagnostic test for the detection and quantification of tuberculosis (TB) bacteria in patients.

Leading experts from around the world are gathered in St Andrews to learn how to dramatically cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives in emerging countries.

The use of whole genome sequencing to identify different strains of bacteria which cause tuberculosis may unlock the door to improved treatments and more accurate clinical trials, according to a new international study.